12-132634277-G-GTTGGATTCCTCCACT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_006231.4(POLE):c.5912_5913insAGTGGAGGAATCCAA(p.Ser1970_Asn1971insLysValGluGluSer) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
POLE
NM_006231.4 inframe_insertion
NM_006231.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.932
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_006231.4.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLE | NM_006231.4 | c.5912_5913insAGTGGAGGAATCCAA | p.Ser1970_Asn1971insLysValGluGluSer | inframe_insertion | 43/49 | ENST00000320574.10 | NP_006222.2 | |
POLE | XM_011534795.4 | c.5912_5913insAGTGGAGGAATCCAA | p.Ser1970_Asn1971insLysValGluGluSer | inframe_insertion | 43/48 | XP_011533097.1 | ||
POLE | XM_011534797.4 | c.4991_4992insAGTGGAGGAATCCAA | p.Ser1663_Asn1664insLysValGluGluSer | inframe_insertion | 35/40 | XP_011533099.1 | ||
POLE | XM_011534802.4 | c.2900_2901insAGTGGAGGAATCCAA | p.Ser966_Asn967insLysValGluGluSer | inframe_insertion | 19/24 | XP_011533104.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLE | ENST00000320574.10 | c.5912_5913insAGTGGAGGAATCCAA | p.Ser1970_Asn1971insLysValGluGluSer | inframe_insertion | 43/49 | 1 | NM_006231.4 | ENSP00000322570 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 06, 2016 | In summary, this variant is a novel in-frame insertion with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a POLE-related disease. This sequence change inserts 15 nucleotides in exon 43 of the POLE mRNA (c.5912_5913insAGTGGAGGAATCCAA). This leads to the insertion of 5 amino acid residues in the POLE protein (p.Ser1970_Asn1971insLysValGluGluSer) but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at